Cheaper Lenacapavir Could Expand HIV Prevention Abroad
A newly approved generic version of lenacapavir may make one of the newest HIV-prevention options more accessible in lower-income countries, while questions remain about rollout, supply and local approval.
U.S. and Zambia finalize a health funding deal after dropping data terms
The agreement sets a five-year health financing package while removing disputed patient-data and specimen-sharing language that had delayed the deal.